pharmaceutical >   Article > New Articles
Current status and recent advances of liver transplantation from donation after cardiac death

Current status and recent advances of liver transplantation from donation after cardiac death

World J Gastrointest Surg 2011 November 27; 3(11): 167-176

M Thamara PR Perera, Simon R Bramhall

 
Immunosuppressive therapy after human lung transplantation

Immunosuppressive therapy after human lung transplantation

Eur Respir J 2004; 23: 159–171

C. Knoop, A. Haverich, S. Fischer
 
Kidney Transplantation: The Ideal Immunosuppression Regimen

Kidney Transplantation: The Ideal Immunosuppression Regimen

Advances in Chronic Kidney Disease, Vol 16, No 4 (July), 226 2009: pp 226-233

Julie M. Yabu and Flavio Vincenti

 
Past, present & future scenario of thalassaemic care & control in India

Past, present & future scenario of thalassaemic care & control in India

Indian J Med Res 134, October 2011, pp 507-521

Ishwar C. Verma, Renu Saxena & Sudha Kohli

 
Oral Iron Chelators: A New Avenue for the Management of Thalassemia Major

Oral Iron Chelators: A New Avenue for the Management of Thalassemia Major

Journal of Current Pharmaceutical Research 2010; 01: 1-7

Ritesh N. Sharma and S. S. Pancholi

 
Chronic kidney disease

Chronic kidney disease

Lancet 2012; 379: 165–80

Andrew S Levey, Josef Coresh

 
The case for wider use of recombinant factor VIII concentrates

The case for wider use of recombinant factor VIII concentrates

Critical reviews in oncology/ hematology

Cedric Hermansa, Hans-Hermann Brackmann, Piercarla Schinco , Günter Auerswald

 
Combined chelation therapy with deferasirox and deferoxamine in thalassemia

Combined chelation therapy with deferasirox and deferoxamine in thalassemia

Blood Cells, Molecules and Diseases 50 (2013) 99–104

Ashutosh Lal, John Porter, Nancy Sweeters , Vivian Ng , Patricia Evans , Lynne Neumayr ,Gregory Kurio , Paul Harmatz , Elliott Vichinsky